SEC Form 4 · accession 0001209191-15-035935
Evoke Pharma Inc · EVOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth J Widder
Director · 10% Owner
Period of report
Apr 22, 2015
Accepted (ET)
Apr 24, 2015 · 2:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001403708
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $6.43 | Apr 22, 2015 | A | 9,000 | A | — | Apr 21, 2025 | Common Stock | 9,000 | 9,000 | D |
Explanation of responses
- F1The total number of shares of common stock subject to the option vests on the one-year anniversary of the date of grant (4/22/2016), subject to the reporting person's continued service to the Issuer through such vesting date.